Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: dates

Announces the Temporary Suspension of Trading of its Shares on Euronext Paris

Suspension 2025

Published 25 November 2025
Categorized as 2025, Press release

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery

P. Erbs, et al. Cancers 2025 Abstract available on the MDPI website – Download the article

Published 19 November 2025
Categorized as -others, 2025, Invir.IO, Publication, TG6002

TG4050 at 2025 SITC: New Ph.I immunological data

link to webcast

Published 14 November 2025
Categorized as 2025, Myvac, TG4050, Webcast, Webcast

VacDesignR®: a Tool for Optimizing Recombinant Poxvirus Vaccine Production

B. Grellier, et al. ESMO-AI 2025 Abstract available on ESMO-AI website – Download the abstract – Download the Poster

Published 12 November 2025
Categorized as 2025, Myvac, Publication, publication key en, TG4050

Profiling of the neoantigen-specific T cell response after adjuvant TG4050 individualized therapeutic vaccination in a randomized phase I trial for locally advanced resected HPV-negative HNSCC

C. Le Tourneau, et al. SITC 2025 Abstract available on JITC website – Download the abstract – Download the Poster

Published 7 November 2025
Categorized as 2025, Myvac, Publication, publication key en, TG4050

Transgene to Showcase Potential of Proprietary VacDesignR® Computational Tool to Optimize Individualized Therapeutic Cancer Vaccines

ESMO AI 2026

Published 6 November 2025
Categorized as 2025, Myvac, Press release, TG4050

Contribution of yeast to synthetic virology

C. Rey, et al. Virologie 2025 Read the article on the JLE website – Download the article

Published 25 October 2025
Categorized as -others, 2025, 2025, Myvac, Publication, Publication, publication key en, TG4050, TG6002

Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors

ESMO Poster

Published 20 October 2025
Categorized as 2025, BT-001, Press release

Updated clinical results of BT-001, an oncolytic virus expressing an anti-CTLA4 mAb,administered in combination with pembrolizumab in patients with advanced solid tumors

C. Lebbe, et al. ESMO 2025 Abstract available on ESMO website – Download the abstract – Download the Poster

Published 20 October 2025
Categorized as 2025, BT-001, Publication, publication key en

Pooled Safety Analysis of Modified Vaccinia Virus Ankara-based Therapeutic Vaccine Alone or in Combination in Cancer and Cervical Intraepithelial Neoplasia (CIN) Clinical Trials

C. Ottensmeier, et al. ESMO 2025 Abstract available on ESMO website – Download the abstract – Download the Poster

Published 19 October 2025
Categorized as -others, 2025, Publication

Posts pagination

Newer posts Page 1 … Page 5 … Page 47 Older posts
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu